J2427 HCPCS code: Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
J2427 is the HCPCS Level II code for injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg. In 2024 Medicare paid an average of $6.36 per service for J2427 across 43,929 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1560 per day on outpatient hospital claims. Medicare volume rose 372% from 2023 to 2024 (9,300 to 43,929 services). In 2024, about 72 clinicians billed Medicare for J2427 for 70 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2023-07-01 |
Who bills J2427 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 72 |
| Medicare beneficiaries | 70 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2427, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 9,300 | 23 | $6.37 | $5.07 |
| 2024 | 43,929 | 70 | $8.01 | $6.36 |
States with the most J2427 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 4,116 | $9.71 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1560 | Prescribing Information |
| practitioner claims | 1560 | Prescribing Information |
What changed for J2427
- 2023-07-01: J2427 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2427?
J2427 is the HCPCS Level II code for injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg. Short descriptor: "Inj, invega hafyera/trinza".
How much does Medicare pay for J2427?
In 2024, the average Medicare payment was $6.36 per service (average allowed $8.01).
Does Medicare cover J2427?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2427 can be billed per day?
1560 on outpatient hospital claims; 1560 on practitioner claims (NCCI medically unlikely edits).
Related J24 codes
- J2400 — Injection, chloroprocaine hydrochloride, per 30 ml
- J2401 — Injection, chloroprocaine hydrochloride, per 1 mg
- J2402 — Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg
- J2403 — Chloroprocaine hcl ophthalmic, 3% gel, 1 mg
- J2404 — Injection, nicardipine, 0.1 mg
- J2405 — Injection, ondansetron hydrochloride, per 1 mg
- J2406 — Injection, oritavancin (kimyrsa), 10 mg
- J2407 — Injection, oritavancin (orbactiv), 10 mg
- J2410 — Injection, oxymorphone hcl, up to 1 mg
- J2425 — Injection, palifermin, 50 micrograms
- J2426 — Injection, paliperidone palmitate extended release (invega sustenna), 1 mg
- J2428 — Injection, paliperidone palmitate extended release (erzofri), 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2427
- Watch J2427 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2427
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.